Clinical trial
Perhexiline therapy in patients with heart failure with preserved left ventricular ejection fraction(HFpEF syndrome)
To test whether perhexiline improve exercise capacity (peak vo2) in patients with heart failure with preserved left ventricular ejection fraction(HFpEFsyndrome)
Category | Value |
---|---|
Study start date | 2006-09-18 |